-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Kc3DkN4xuPEzJYwpuuU9cSWI0qPmW5QrRG85IPXnGH4BGxsd6pXAM2JssTYChqUj ADKAKzPp3YqmQ9DLbpw+yg== 0001186120-05-000017.txt : 20050321 0001186120-05-000017.hdr.sgml : 20050321 20050321145900 ACCESSION NUMBER: 0001186120-05-000017 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050317 FILED AS OF DATE: 20050321 DATE AS OF CHANGE: 20050321 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVANIR PHARMACEUTICALS CENTRAL INDEX KEY: 0000858803 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330314804 STATE OF INCORPORATION: CA FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD STREET 2: STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8586225200 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: LIDAK PHARMACEUTICALS DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Podlesak Dennis CENTRAL INDEX KEY: 0001314595 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15803 FILM NUMBER: 05694011 BUSINESS ADDRESS: BUSINESS PHONE: (510) 747-3900 MAIL ADDRESS: STREET 1: C/O PENINSULA PHARMACEUTICALS, INC. STREET 2: 1751 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 3 1 edgardoc.xml PRIMARY DOCUMENT X0202 3 2005-03-17 0 0000858803 AVANIR PHARMACEUTICALS AVN 0001314595 Podlesak Dennis 11388 SORRENTO VALLEY ROAD, SUTIE 200 SAN DIEGO CA 92121 1 0 0 0 Non-Qualified Stock Option (right to buy) 2.48 2006-03-17 2015-03-17 Class A Common Stock 25000 D Form 3 is filed to report shares of Class A Common Stock and/or options owned by the reporting person on the date he/she became a director. Options vest as follows: One-third of the Shares on the first anniversary of the date of the director's initial election to the Board and with respect to an additional one-twelfth of the Shares quarterly thereafter for the next two years. Dennis G Podlesak 2005-03-21 -----END PRIVACY-ENHANCED MESSAGE-----